CoV2-M-IRES-E Citations (11)
Originally described in: Rapid assessment of SARS-CoV-2 evolved variants using virus-like particles.Syed AM, Taha TY, Tabata T, Chen IP, Ciling A, Khalid MM, Sreekumar B, Chen PY, Hayashi JM, Soczek KM, Ott M, Doudna JA Science. 2021 Nov 4:eabl6184. doi: 10.1126/science.abl6184. PubMed Journal
Articles Citing CoV2-M-IRES-E
| Articles |
|---|
| Virus-like particle - mediated delivery of the RIG-I agonist M8 induces a type I interferon response and protects cells against viral infection. Palermo E, Alexandridi M, Di Carlo D, Muscolini M, Hiscott J. Front Cell Infect Microbiol. 2022 Dec 14;12:1079926. doi: 10.3389/fcimb.2022.1079926. eCollection 2022. PubMed |
| Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry. Sengar A, Cervantes M, Bondalapati ST, Hess T, Kasson PM. J Virol. 2023 May 31;97(5):e0199222. doi: 10.1128/jvi.01992-22. Epub 2023 May 3. PubMed |
| Development of novel SARS-CoV-2 viral vectors. Liu H, Liu D. Sci Rep. 2023 Aug 11;13(1):13053. doi: 10.1038/s41598-023-40370-8. PubMed |
| Effects of N-glycan modifications on spike expression, virus infectivity, and neutralization sensitivity in ancestral compared to Omicron SARS-CoV-2 variants. Lusvarghi S, Stauft CB, Vassell R, Williams B, Baha H, Wang W, Neerukonda SN, Wang T, Weiss CD. PLoS Pathog. 2023 Nov 9;19(11):e1011788. doi: 10.1371/journal.ppat.1011788. eCollection 2023 Nov. PubMed |
Tuning the tropism and infectivity of SARS-CoV-2 virus-like particles for mRNA delivery.
Yang Q, Davidson BA, Pajic P, Chen X, Gokcumen O, Gao M, Neelamegham S.
Nucleic Acids Res. 2025 Feb 27;53(5):gkaf133. doi: 10.1093/nar/gkaf133.
PubMed
Associated Plasmids |
| Tradeoffs between proliferation and transmission in virus evolution- insights from evolutionary and functional analyses of SARS-CoV-2. Tai JH, Lee DC, Lin HF, Chao TL, Ruan Y, Cheng YW, Chou YC, Lin YY, Chang SY, Chen PJ, Yeh SH, Wang HY. Virol J. 2025 Apr 19;22(1):107. doi: 10.1186/s12985-025-02727-5. PubMed |
| Electromagnetic waves destabilize the SARS-CoV-2 Spike protein and reduce SARS-CoV-2 Virus-Like particle (SC2-VLP) infectivity. Pantoja C, Acosta FM, Granatir S, Anderson M, Wyr M, Tailor J, Fuori A, Dower W, Marr HB, Ramirez PW. Sci Rep. 2025 May 15;15(1):16836. doi: 10.1038/s41598-025-01896-1. PubMed |
| Anticoronavirus Activity of Uridine Glycoconjugates Containing a 1,2,3-Triazole Moiety. Graul M, Brzuska G, Wisniewska E, Dominska M, Strakova P, Ruzek D, Pastuch-Gawolek G, Krol E. J Med Chem. 2025 Aug 28;68(16):17859-17873. doi: 10.1021/acs.jmedchem.5c01602. Epub 2025 Aug 8. PubMed |
| SARS-CoV-2 membrane protein recruits PP2A to dephosphorylate the nucleocapsid and promote virion production. Wang SH, Chao TL, Hsieh CL, Chen PJ, Chang SY, Yeh SH. J Biomed Sci. 2026 May 15;33(1):51. doi: 10.1186/s12929-026-01255-w. PubMed |
| Involvement of 5' and 3' UTRs in SARS-CoV-2 Virus-like Particle Genome Packaging. Zhang Z, Yang K, Shao F, Shen W, Li P, Zhang Y, Xu J, Xie D, Wang C, Yu G, Zhang J, Zhao Z, Zhang Y. Viruses. 2026 Jun 25;18(7):700. doi: 10.3390/v18070700. PubMed |
| SARS-CoV-2 nucleocapsid induces hyperinflammation and vascular leakage through the Toll-like receptor signaling axis in macrophages. Yao Z, Alvarez PA, Chavez C, Delgado Y, Kaushal P, Buchholz DW, Austin D, Li Q, Yu Y, Zaiss AK, Arumugaswami V, Ding Q, Hsu JJ, Damoiseaux R, Aguilar HC, Bouhaddou M, Hoffmann A, Li MMH. Sci Adv. 2026 Aug 7;12(32):eaea2780. doi: 10.1126/sciadv.aea2780. Epub 2026 Aug 5. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.